LIFESTYLE CHI (02136) releases annual performance, shareholders' net loss widens by 54.84% year-on-year to 31.13 million yuan.
LiFu China (02136) announced its annual performance for the year ending on December 31, 2025. The group achieved a revenue of 1.211 billion yuan, a decrease of 3.35% year-on-year; the loss attributable to shareholders was 31.131 million yuan, an increase of 54.84% year-on-year; and the basic loss per share was 0.021 yuan.
LIFESTYLE CHI (02136) published its annual performance for the year ending December 31, 2025. The group achieved revenue of RMB 1.211 billion, a decrease of 3.35% year-on-year; shareholders' net loss was RMB 31.131 million, an increase of 54.84% year-on-year; basic loss per share was RMB 0.021.
The announcement stated that the increase in shareholders' net loss was mainly due to a decrease in gross profit caused by promoting consumption, leading to a decline in gross profit, and the group's share of the profit of its associated company Beiren Group decreased by 18.9% to approximately RMB 112 million. However, this was offset by a 12.4% decrease in financing costs to RMB 163.7 million, partially offsetting the loss. The group's operating loss before tax (excluding the share of profits of associated companies and a joint venture) for the year was RMB 80.9 million, compared to RMB 61.8 million in 2024.
Related Articles

JPMorgan Chase (JPM.US) adjusts Electronic Arts Inc. (EA.US) acquisition debt structure, increases the US dollar loan amount to 5 billion US dollars.

Eternal Beauty (06883): Li Zhuoran appointed as Independent Non-Executive Director of the Company

TIANAN MEDICARE (00383) plans to offer a premium of approximately 15.79% to repurchase up to a maximum of 70 million shares. Resumption of trading on March 24th.
JPMorgan Chase (JPM.US) adjusts Electronic Arts Inc. (EA.US) acquisition debt structure, increases the US dollar loan amount to 5 billion US dollars.

Eternal Beauty (06883): Li Zhuoran appointed as Independent Non-Executive Director of the Company

TIANAN MEDICARE (00383) plans to offer a premium of approximately 15.79% to repurchase up to a maximum of 70 million shares. Resumption of trading on March 24th.






